直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Offices
  • Careers
Finnegan
  • Articles & Books
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • IP Health Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
  • Unified Patent Court (UPC) Hub

Podcast

Is the Label Skinny Enough?

April 2022

By Mark J. Feldstein, Ph.D.; Cora R. Holt; Thomas L. Irving

In this podcast, Finnegan attorneys Mark Feldstein, Cora Holt, and Tom Irving discuss the impacts of the recent Federal Circuit cases GSK v. Teva and Amarin v. Hikma.

A closed captioning version is available here. 

Audio Only:

Tags

United States Court of Appeals for the Federal Circuit (CAFC), drugs, Food and Drug Administration (FDA)

Downloadable Files

  • Podcast - Is the Label Skinny Enough?

Related Practices

Patent Litigation

Appeals

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Washington, DC

Related Professionals

Mark_Feldstein
Mark J. Feldstein, Ph.D.
Partner
Washington, DC
+1 202 408 4092
Email
Cora R. Holt
Partner
Washington, DC
+1 202 408 4334
Email
Thomas_Irving
Thomas L. Irving
Partner
Washington, DC
+1 202 408 4082
Email

Related Insights

Prosecution First Blog

Expecting the “Unexpected”: Asserted Claims Found Invalid After Allegedly “Unexpected Results” Suggested in Prior Art References

January 27, 2023

Seminar

Patent Protection for Software-Related Inventions: Patent Law in Europe and the US

January 26, 2023

Oslo

Articles

Patent Infringement: When Is a Product Sold “Within the United States”?

November/December 2023

Articles

IP Issues Surrounding Machine Learning and AI in the Pharmaceutical Space

January 2023

Articles

Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences

January 2023

Webinar

Forum Shopping and the UPC

January 19, 2023

Webinar

Prosecution First Blog

Federal Circuit Clarifies the Standard of Review for Invalidity Challenges

January 13, 2023

At the PTAB Blog

Possible Defects Won’t Render Prior Art Inoperative

January 12, 2023

Articles

Drive Your Company's IP Strategy

January 12, 2023

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).

Finnegan
Click Here
  • Privacy
  • Disclaimer
  • EEO Statement

© 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP